Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q866F0

Entry ID Method Resolution Chain Position Source
AF-Q866F0-F1 Predicted AlphaFoldDB

No variants for Q866F0

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q866F0

No associated diseases with Q866F0

No regional properties for Q866F0

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q866F0

Functions

Description
EC Number 2.4.1.69 Hexosyltransferases
Subcellular Localization
  • Golgi apparatus, Golgi stack membrane ; Single-pass type II membrane protein
  • Membrane-bound form in trans cisternae of Golgi
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
Golgi cisterna membrane The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

2 GO annotations of molecular function

Name Definition
alpha-(1,2)-fucosyltransferase activity Catalysis of the transfer of an L-fucosyl group from GDP-beta-L-fucose to an acceptor molecule to form an alpha-(1->2) linkage.
galactoside 2-alpha-L-fucosyltransferase activity Catalysis of the reaction: GDP-L-fucose + beta-D-galactosyl-R = GDP + alpha-L-fucosyl-(1,2)-beta-D-galactosyl-R.

11 GO annotations of biological process

Name Definition
carbohydrate metabolic process The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
fucosylation The covalent attachment of a fucosyl group to an acceptor molecule.
lipid metabolic process The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
olfactory bulb development The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex.
positive regulation of cell-matrix adhesion Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix.
positive regulation of endothelial cell migration Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
positive regulation of endothelial cell-matrix adhesion via fibronectin Any process that activates or increases the frequency, rate or extent of endothelial cell-matrix adhesion via fibronectin.
positive regulation of sprouting angiogenesis Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
protein glycosylation A protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
regulation of cell adhesion Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.
regulation of endothelial cell proliferation Any process that modulates the frequency, rate, or extent of endothelial cell proliferation.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MWPRSHRHLC LAFLLVCVLS AISFLIHFHQ DSIRHGLGLS VLCPDRRLVT PAVAIFCLPG
70 80 90 100 110 120
TPMSPNTSSS CPQHPASLSG TWTIYPDGRF GNQMGQYATL LALAQLNGRR AFILPAMHAA
130 140 150 160 170 180
LAPVFRITLP VLAPEVDSRT PWQELRLHDW MSEEYADLGD PFLKLSGFPC SWTFFHHLRE
190 200 210 220 230 240
QIRSEFTLHD HLREEAQSVL RRLRLGRSGA RPRTFVGVHV RRGDYLQVMP QRWKGVVANS
250 260 270 280 290 300
AYLREAMDWF RARHEAPVFV VTSNGMEWCR ENIDASKGDV MFAGDGQEAS PWKDFALLTQ
310 320 330 340 350 360
CNHTIMTIGT FGFWAAYLAG GDTVYLANFT LPDSEFLKIF KPEAAFLPEW VGINADLSPL
WPLAEP